A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion TherapyXiaoxi Yang 1, Taylor D. Osborne 1, Martha Delahunty 2, Marilyn J. Telen 2, Jason S. Kim 1
1BioMedomics Inc., 2Division of Hematology, Department of Medicine, Duke University Medical Center
We have developed a point-of-care immunoassay to rapidly quantify hemoglobin S (HbS) levels during transfusion therapy for sickle cell disease (SCD) patients. By applying a small amount of treated blood to the device, the healthcare provider can determine the %HbS in a SCD patient to immediately inform clinical decisions.
